Hematological Malignancies B
2 clinical trials · Condition
◉ Watch Hematological Malignancies B
| Record | Firm | Date |
|---|---|---|
| Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological Malignancies (NCT07670949) | Zhejiang Cancer Hospital | 2026-06-01 |
| Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies B (NCT02844491) | Centre Hospitalier Universitaire de Besancon | 2013-01-22 |
Track Hematological Malignancies B automatically
Every clearance here is in the API, with alerts when new ones post.